Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1998-2002, November 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ertürk, E.
Right arrow Articles by Crovetti, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ertürk, E.
Right arrow Articles by Crovetti, A. J.

The Production of Carcinoma of the Urinary Bladder in Rats by Feeding N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide1

E. Ertürk[1], J. M. Price[1],2, J. Emory Morris3, S. Cohen[1], Ronnie Sue Leith[1], Anne M. Von Esch[2] and A. J. Crovetti[2]

[1] Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin 53706
[2] Department of Organic Chemical Research, Scientific Divisions, Abbott Laboratories, North Chicago, Illinois 60064

Thirty female Sprague-Dawley rats were fed 0.188% of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for 46 weeks. Twenty-nine of the rats lived 34 weeks or more and all of these animals developed gross bladder carcinomas. Three rats developed carcinomas of the renal pelvis which invaded the kidney. There were 15 animals with 1 or more gross mammary tumors, all of which were classified as benign adenoma, fibroadenoma, or adenofibroma. This is the first nitrofuran derivative which has been found to be a bladder carcinogen, and the compound appears to be one of the most effective bladder carcinogens for this species.

1 This research was supported by a grant from the American Cancer Society and Contract No. PH 43-66-888 from the National Cancer Institute.

2 American Cancer Society—Charles S. Hayden Foundation Professor of Surgery in Cancer Research.

3 Present address: Pahlavi University, Department of Biochemistry, c/o American Peace Corps, Khiaban Zand, Kucheh Yaghma, Shiraz, Iran.

Received 3/20/67. Accepted 6/22/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.